Lantern Pharma Inc (LTRN)
Healthcare
Biotechnology
2.60 $
-0.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Lantern Pharma Inc (LTRN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -3.8 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.6 | -3.6 | -3.4 | -3.1 | -5.2 | -5.6 | -4.0 | -4.4 | -3.9 | -4.6 | -2.8 | -3.8 | -15 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.4 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.3 | 0.1 | 0.2 | 0.1 | 0.2 | 0.3 | 0.8 | |
| 0.5 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.7 | -0.8 | 0.9 | 2.1 | -0.3 | -0.9 | 1.3 | 0.1 | 0.4 | -0.7 | 0.8 | -0.8 | -0.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.5 | 0.2 | 0.3 | -0.6 | -0.2 | 0.7 | 3.4 | 3.2 | 3.6 | 5.9 | -1.7 | 4.3 | 12 | |
| 0.0 | 0.0 | -0.5 | – | – | – | – | – | – | – | – | – | – | |
| -0.7 | 0.0 | -0.5 | 0.1 | 0.0 | 0.0 | 0.0 | 67 | 0.0 | 1.0 | 0.5 | – | – | |
| -4.1 | -3.4 | -3.6 | -3.6 | -5.4 | -4.9 | -0.6 | -1.1 | -0.3 | 2.3 | -4.0 | 0.5 | -1.5 | |
| -3.6 | -3.6 | -3.4 | -3.1 | -5.2 | -5.6 | -4.0 | -4.4 | -3.9 | -4.6 | -2.8 | -3.8 | -15 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.